NPPA seeks clarification on Gilead’s drug pricing plea

NEW DELHI: India’s drug pricing regulator has raised a red flag against price exemption plea made by US drug maker Gilead Sciences for its medicine for treatment of chronic Hepatitis B, revealed NPPA in its minutes of the meeting. Observing that the submission by Gilead was also tantamount to ever greening, which would mean a… Continue reading NPPA seeks clarification on Gilead’s drug pricing plea

SCHOTT increases sales in India and plans record investments

Germany headquartered SCHOTT AG, international specialty glass and technical ceramic materials manufacturer, has continued on its growth course in fiscal year 2018/19 (October 1, 2018, to September 30, 2019). Its key financial figures developed positively or remained at a solid level from previous year. “We are pleased with the past fiscal year. We were able… Continue reading SCHOTT increases sales in India and plans record investments

Christopher Rudolf: Defining New Ways to Diagnose Diseases and Help Patients

The reality of healthcare data is that it is messy, sparse and varies in structure enormously between different systems, countries and languages. Over the last ten years, the Volv team has developed original and innovative mathematics to allow the company to be able to derive value from this data unchanged. Volv Global provides applied data… Continue reading Christopher Rudolf: Defining New Ways to Diagnose Diseases and Help Patients

Guha on ‘harmoniser’ Gandhi, Lavasa calls India’s first elections ‘fateful experiment’

File photo of Mahatma Gandhi | Central Press/Getty Images Text Size: Great harmoniser of India’s diversity Ramachandra Guha| Historian and author of ‘Gandhi: The Years that Changed the World 1914-1948’ Hindustan Times Guha states that when Gandhi came back from South Africa he initially stayed at the house of S.K. Rudra, Principal of St. Stephen’s… Continue reading Guha on ‘harmoniser’ Gandhi, Lavasa calls India’s first elections ‘fateful experiment’

India’s production of paracetamol, top antibiotics could be hit by China coronavirus crisis

Children wearing facial masks, as a precaution after Nepal confirmed the first case of coronavirus in the country, attend a lecture at Matribhumi School in Thimi, Bhaktapur, Nepal on Wednesday | ANI/Reuters Text Size: New Delhi: The supply of raw materials to produce top-selling antibiotics, anti-diabetic medicines and commonly used paracetamol could be hit in… Continue reading India’s production of paracetamol, top antibiotics could be hit by China coronavirus crisis

Key drug ingredients, electronic parts may run short as coronavirus threatens supply

Written by Prabha Raghavan , Sandeep Singh | Alka Pande & Ravish Tiwarilucknow/new Delhi, New Delhi | Updated: January 30, 2020 4:27:57 am China, earlier this week, decided to extend its Lunar New Year holiday to February 2 to control the spread of the virus.India’s dependence on China for certain key ingredients used to make… Continue reading Key drug ingredients, electronic parts may run short as coronavirus threatens supply

Pharma firms brace for raw material supply issues due to coronavirus outbreak

Pharmaceutical companies in India are bracing for a hit on supply of key raw materials, majority of which is imported from China, if the current outbreak of novel coronavirus infection continues. “We buy antibiotics and vitamins in a big way from them (Chinese manufacturers). As of now, there is no problem but we will have… Continue reading Pharma firms brace for raw material supply issues due to coronavirus outbreak

Baby green steps by Himachal

Shimla: The Himachal Pradesh government is committed to ensuring sustainability of environmental heritage and natural resources, It has implemented climate change policy in the state, giving top priority to environmental conservation, a spokesman of the state government claimed today. “For creating awareness amongst the public to adopt a pollution free energy for environmental conservation, Roof… Continue reading Baby green steps by Himachal

‘In a digital world’ – Experts call for digital pharma

You are here: Home / Digital health / ‘In a digital world’ – Experts call for digital pharma January 29, 2020 By Kerean Watts Leave a Comment Multiple stakeholders from the Indian pharmaceutical and healthcare industries are calling for increased digitisation, arguing that a trend towards ‘digital pharma’ is fuelling the sector’s growth. “To understand… Continue reading ‘In a digital world’ – Experts call for digital pharma